Literature DB >> 19706600

Tumor necrosis factor-alpha induces RelA degradation via ubiquitination at lysine 195 to prevent excessive nuclear factor-kappaB activation.

Yihui Fan1, Renfang Mao, Yanling Zhao, Yang Yu, Wenjing Sun, Ping Song, Zhongcheng Shi, Dekai Zhang, Eric Yvon, Hong Zhang, Songbin Fu, Jianhua Yang.   

Abstract

Ubiquitination-mediated degradation of the RelA subunit of nuclear factor-kappaB (NF-kappaB) is critical for the termination of NF-kappaB activation. However, the precise mechanism for the ubiquitination of RelA is still not fully understood. Here we report that tumor necrosis factor-alpha (TNFalpha) induces RelA polyubiquitination at the lysine 195 residue, and this ubiquitination event is critical for the degradation of RelA and termination of TNFalpha-mediated NF-kappaB activation. Overexpression of a RelA mutant with an arginine substitution for the lysine 195 residue dramatically inhibits RelA polyubiquitination and induces a stronger NF-kappaB activation compared with the wild type. Reconstitution of RelA-deficient mouse embryo fibroblast cells with wild-type RelA or RelA containing a K195R mutation revealed the importance of this site in TNFalpha-mediated RelA polyubiquitination, degradation, and attenuation of NF-kappaB activation. Our finding is the first report that substitution of a key RelA lysine residue with arginine inhibits TNFalpha-induced RelA ubiquitination and enhances TNFalpha-induced NF-kappaB activation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19706600      PMCID: PMC2785559          DOI: 10.1074/jbc.M109.018994

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

Review 1.  Signaling to NF-kappaB.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2004-09-15       Impact factor: 11.361

Review 2.  Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

Authors:  I M Verma; J K Stevenson; E M Schwarz; D Van Antwerp; S Miyamoto
Journal:  Genes Dev       Date:  1995-11-15       Impact factor: 11.361

3.  Interleukin-6 induction by tumor necrosis factor and interleukin-1 in human fibroblasts involves activation of a nuclear factor binding to a kappa B-like sequence.

Authors:  Y H Zhang; J X Lin; J Vilcek
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

4.  Involvement of a NF-kappa B-like transcription factor in the activation of the interleukin-6 gene by inflammatory lymphokines.

Authors:  H Shimizu; K Mitomo; T Watanabe; S Okamoto; K Yamamoto
Journal:  Mol Cell Biol       Date:  1990-02       Impact factor: 4.272

Review 5.  The I kappa B proteins: multifunctional regulators of Rel/NF-kappa B transcription factors.

Authors:  A A Beg; A S Baldwin
Journal:  Genes Dev       Date:  1993-11       Impact factor: 11.361

Review 6.  The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Authors:  D M Rothwarf; M Karin
Journal:  Sci STKE       Date:  1999-10-26

7.  Activation of interleukin-6 gene expression through the NF-kappa B transcription factor.

Authors:  T A Libermann; D Baltimore
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

8.  Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B.

Authors:  A A Beg; W C Sha; R T Bronson; S Ghosh; D Baltimore
Journal:  Nature       Date:  1995-07-13       Impact factor: 49.962

9.  Degradation of promoter-bound p65/RelA is essential for the prompt termination of the nuclear factor kappaB response.

Authors:  Simona Saccani; Ivan Marazzi; Amer A Beg; Gioacchino Natoli
Journal:  J Exp Med       Date:  2004-06-28       Impact factor: 14.307

10.  Termination of NF-kappaB activity through a gammaherpesvirus protein that assembles an EC5S ubiquitin-ligase.

Authors:  Lénia Rodrigues; Josina Filipe; Mark P Seldon; Lidia Fonseca; Josef Anrather; Miguel P Soares; J Pedro Simas
Journal:  EMBO J       Date:  2009-03-26       Impact factor: 11.598

View more
  12 in total

Review 1.  NF-κB addiction and its role in cancer: 'one size does not fit all'.

Authors:  M M Chaturvedi; B Sung; V R Yadav; R Kannappan; B B Aggarwal
Journal:  Oncogene       Date:  2010-12-20       Impact factor: 9.867

2.  High throughput short interfering RNA (siRNA) screening of the human kinome identifies novel kinases controlling the canonical nuclear factor-κB (NF-κB) activation pathway.

Authors:  Sanjeev Choudhary; Kevin P Rosenblatt; Ling Fang; Bing Tian; Zhao-Hui Wu; Allan R Brasier
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

Review 3.  Ubiquitin-mediated NFκB degradation pathway.

Authors:  Huimin Xu; Mengli You; Haifeng Shi; Yongzhong Hou
Journal:  Cell Mol Immunol       Date:  2014-10-27       Impact factor: 11.530

4.  Hyper-O-GlcNAcylation activates nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB) signaling through interplay with phosphorylation and acetylation.

Authors:  Zhiyuan Ma; Robert J Chalkley; Keith Vosseller
Journal:  J Biol Chem       Date:  2017-04-17       Impact factor: 5.157

5.  Ski regulates Hippo and TAZ signaling to suppress breast cancer progression.

Authors:  Juliet Rashidian; Erwan Le Scolan; Xiaodan Ji; Qingwei Zhu; Melinda M Mulvihill; Daniel Nomura; Kunxin Luo
Journal:  Sci Signal       Date:  2015-02-10       Impact factor: 8.192

6.  Hyper-O-GlcNAcylation is anti-apoptotic and maintains constitutive NF-κB activity in pancreatic cancer cells.

Authors:  Zhiyuan Ma; David J Vocadlo; Keith Vosseller
Journal:  J Biol Chem       Date:  2013-04-16       Impact factor: 5.157

7.  NF-κB p65 repression by the sesquiterpene lactone, Helenalin, contributes to the induction of autophagy cell death.

Authors:  Chuan Bian Lim; Pan You Fu; Nung Ky; Hong Shuang Zhu; XiaoLing Feng; Jinming Li; Kandhadayar Gopalan Srinivasan; Mohamed Sabry Hamza; Yan Zhao
Journal:  BMC Complement Altern Med       Date:  2012-07-11       Impact factor: 3.659

8.  Regulation of NF-κB activity by competition between RelA acetylation and ubiquitination.

Authors:  H Li; T Wittwer; A Weber; H Schneider; R Moreno; G N Maine; M Kracht; M L Schmitz; E Burstein
Journal:  Oncogene       Date:  2011-06-27       Impact factor: 9.867

9.  NF-κB signaling in the brain of autistic subjects.

Authors:  Mazhar Malik; Zujaja Tauqeer; Ashfaq M Sheikh; Guang Wen; Amenah Nagori; Kun Yang; W Ted Brown; Xiaohong Li
Journal:  Mediators Inflamm       Date:  2011-10-20       Impact factor: 4.711

Review 10.  Role of transcription factor modifications in the pathogenesis of insulin resistance.

Authors:  Mi-Young Kim; Jin-Sik Bae; Tae-Hyun Kim; Joo-Man Park; Yong Ho Ahn
Journal:  Exp Diabetes Res       Date:  2011-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.